Year-end Sale % OFF 
Abstract
Chemotherapy-induced nausea and vomiting (CINV) prevention is important to reduce overall morbidity and financial burden in patients receiving chemotherapy. Severe symptoms reduce the patient's quality of life and can interfere with further treatment. The five major forms of CINV (ie, acute, delayed, predicted, breakthrough, and refractory) often include 5-HT3 receptor antagonists, NK1 receptor antagonists, and various treatments that often include corticosteroids. Despite significant research and development efforts on antiemetics, treatment of CINV remains a major challenge, waiting for many needs to be adequately addressed, including those that are vulnerable to CINV despite adequately treated. This review hope to raise awareness and discuss current current CINV management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
